Skip Navigation


Brain Advance Access originally published online on July 7, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
126/9/1940    most recent
awg197v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Floßmann, E.
Right arrow Articles by Rothwell, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Floßmann, E.
Right arrow Articles by Rothwell, P. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 126, No. 9, 1940-1954, September 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg197

Prognosis of vertebrobasilar transient ischaemic attack and minor stroke

Enrico Floßmann and Peter M. Rothwell

Stroke Prevention Research Unit, University Department of Clinical Neurology, Radcliffe Infirmary, Oxford, UK

Correspondence to: Dr P. M. Rothwell, Stroke Prevention Research Unit, Department of Clinical Neurology, Radcliffe Infirmary, Woodstock Road, Oxford OX2 6HE, UK E-mail: peter.rothwell{at}clneuro.ox.ac.uk

Vertebrobasilar (VB) territory transient ischaemic attacks (TIAs) and minor strokes are perceived to have a better prognosis than carotid territory events, and are sometimes managed less aggressively. However, this notion stems mainly from a few small studies in the 1960s and 1970s, and has not been systematically tested. We therefore identified all published studies of prognosis after TIA or minor stroke using MEDLINE and EMBASE, and hand-searching reference lists and relevant journals. In addition, we attempted to include all available individual patient data (IPD) from studies that had not published outcome data by territory of presenting event. Odds of recurrent events were calculated within studies and combined by fixed-effects meta-analysis. Heterogeneity between studies was calculated using the {chi}2 method. We stratified the analysis by time interval between presenting event and inclusion in study, and by study setting (population-based, published hospital-based and unpublished hospital-based). Public ation bias was tested for by linear regression of the standard normal deviate against precision. Eight hundred and twenty abstracts were reviewed, and 304 papers were considered in detail. Of these, 43 studies representing 36 independent cohorts (12 196 patients) reported outcomes by territory of presenting event. IPD from five studies (4643 patients) were also included. The following results compare relative risks of VB with carotid events. Studies including the acute phase (up to 7 days) after the presenting event found a higher relative risk of subsequent stroke in patients with VB events [odds ratio (OR) 1.47, 95% confidence interval (CI) 1.1–2.0, P = 0.014]. Conversely, studies mainly recruiting after the acute phase found a lower relative risk (OR 0.74, 95% CI 0.7–0.8, P = 0.00001). In published hospital-based studies, the risk of recurrent stroke was lower for patients presenting with VB events (OR 0.68, 95% CI 0.6–0.8, P < 0.00001). However, there was no difference in hospital-based IPD (OR 1.02, 95% CI 0.8–1.3, P = 0.91). Moreover, in population-based studies, patients with VB events had a higher risk of stroke (OR 1.48, 95% CI 1.1–2.0, P = 0.025). There was no within-stratum heterogeneity. There was no difference in the risk of fatal stroke (OR 1.04, 95% CI 0.8–1.4, P = 0.90). Therefore, we found no evidence that patients presenting with VB events have a lower risk of subsequent stroke or death compared with patients presenting with carotid TIA or minor stroke. Indeed, their risk of stroke is probably higher in the acute phase. Patients with VB events require active preventive treatment.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
StrokeHome page
E. Flossmann, J. N. Redgrave, D. Briley, and P. M. Rothwell
Reliability of Clinical Diagnosis of the Symptomatic Vascular Territory in Patients With Recent Transient Ischemic Attack or Minor Stroke
Stroke, September 1, 2008; 39(9): 2457 - 2460.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Ois, M. Gomis, A. Rodriguez-Campello, E. Cuadrado-Godia, J. Jimenez-Conde, C. Pont-Sunyer, G. Cuccurella, and J. Roquer
Factors Associated With a High Risk of Recurrence in Patients With Transient Ischemic Attack or Minor Stroke
Stroke, June 1, 2008; 39(6): 1717 - 1721.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Khan, G C Cloud, S Kerry, and H S Markus
Imaging of vertebral artery stenosis: a systematic review
J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1218 - 1225.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. J. Coward, D. J.H. McCabe, J. Ederle, R. L. Featherstone, A. Clifton, M. M. Brown, and on behalf of the CAVATAS Investigators
Long-Term Outcome After Angioplasty and Stenting for Symptomatic Vertebral Artery Stenosis Compared With Medical Treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): A Randomized Trial
Stroke, May 1, 2007; 38(5): 1526 - 1530.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
P M Rothwell
Atherothrombosis and ischaemic stroke
BMJ, February 24, 2007; 334(7590): 379 - 380.
[Full Text] [PDF]


Home page
StrokeHome page
P. M. Rothwell and S. C. Johnston
Transient Ischemic Attacks: Stratifying Risk
Stroke, February 1, 2006; 37(2): 320 - 322.
[Full Text] [PDF]


Home page
StrokeHome page
M. Correia, M. R. Silva, R. Magalhaes, L. Guimaraes, and M. Carolina Silva
Transient Ischemic Attacks in Rural and Urban Northern Portugal: Incidence and Short-Term Prognosis
Stroke, January 1, 2006; 37(1): 50 - 55.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. J. Hankey, L. J. Coward, R. L. Featherstone, and M. M. Brown
Percutaneous Transluminal Angioplasty and Stenting for Vertebral Artery Stenosis
Stroke, September 1, 2005; 36(9): 2047 - 2048.
[Full Text] [PDF]


Home page
J Ultrasound MedHome page
J. U. Harrer, T. Wessels, S. Poerwowidjojo, W. Moller-Hartmann, and C. Klotzsch
Three-Dimensional Color-Coded Duplex Sonography for Assessment of the Vertebral Artery Origin and Vertebral Artery Stenoses
J. Ultrasound Med., August 1, 2004; 23(8): 1049 - 1056.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. J. Coull and P. M. Rothwell
Underestimation of the Early Risk of Recurrent Stroke: Evidence of the Need for a Standard Definition
Stroke, August 1, 2004; 35(8): 1925 - 1929.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. G. Rudd and D. B. Matchar
Health Policy and Outcome Research in Stroke
Stroke, February 1, 2004; 35(2): 397 - 400.
[Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P A G Sandercock
Should I start all my ischaemic stroke and TIA patients on a statin, an ACE inhibitor, a diuretic, and aspirin today?
J. Neurol. Neurosurg. Psychiatry, November 1, 2003; 74(11): 1461 - 1464.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.